Beijing Chunlizhengda Medical Instruments Co., Ltd. (688236.SS)
CNY 13.6
(-1.16%)
CNY 13.6
(-1.16%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 1.19 Billion CNY | -0.33% |
| 2022 | 1.2 Billion CNY | 8.43% |
| 2021 | 1.1 Billion CNY | 18.18% |
| 2020 | 937.68 Million CNY | 9.63% |
| 2019 | 855.32 Million CNY | 71.78% |
| 2018 | 497.92 Million CNY | 65.8% |
| 2017 | 300.31 Million CNY | 44.43% |
| 2016 | 207.92 Million CNY | 17.23% |
| 2015 | 177.36 Million CNY | 31.84% |
| 2014 | 134.53 Million CNY | 21.7% |
| 2013 | 110.54 Million CNY | 12.69% |
| 2012 | 98.09 Million CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q3 | 126.48 Million CNY | -20.09% |
| 2024 Q1 | 220.01 Million CNY | -46.5% |
| 2024 Q2 | 158.28 Million CNY | -28.06% |
| 2023 Q1 | 244.82 Million CNY | -44.57% |
| 2023 FY | 1.19 Billion CNY | -0.33% |
| 2023 Q2 | 291.86 Million CNY | 19.21% |
| 2023 Q4 | 411.25 Million CNY | 63.56% |
| 2023 Q3 | 251.44 Million CNY | -13.85% |
| 2022 Q1 | 254.6 Million CNY | -34.68% |
| 2022 Q4 | 441.63 Million CNY | 134.2% |
| 2022 Q3 | 188.57 Million CNY | -39.03% |
| 2022 Q2 | 309.26 Million CNY | 21.47% |
| 2022 FY | 1.2 Billion CNY | 8.43% |
| 2021 FY | 1.1 Billion CNY | 18.18% |
| 2021 Q3 | 235.76 Million CNY | -7.91% |
| 2021 Q4 | 389.74 Million CNY | 65.31% |
| 2021 Q1 | 224.95 Million CNY | -15.22% |
| 2021 Q2 | 256 Million CNY | 13.8% |
| 2020 Q3 | 265.34 Million CNY | 6.45% |
| 2020 FY | 937.68 Million CNY | 9.63% |
| 2020 Q4 | 265.34 Million CNY | 0.0% |
| 2020 Q2 | 249.26 Million CNY | 58.04% |
| 2020 Q1 | 157.72 Million CNY | -34.33% |
| 2019 Q3 | 240.17 Million CNY | 28.1% |
| 2019 Q2 | 187.49 Million CNY | 0.0% |
| 2019 Q4 | 240.17 Million CNY | 0.0% |
| 2019 Q1 | 187.49 Million CNY | 31.67% |
| 2019 FY | 855.32 Million CNY | 71.78% |
| 2018 Q2 | 106.57 Million CNY | -0.0% |
| 2018 FY | 497.92 Million CNY | 65.8% |
| 2018 Q4 | 142.39 Million CNY | 0.0% |
| 2018 Q3 | 142.39 Million CNY | 33.61% |
| 2018 Q1 | 106.57 Million CNY | 21.05% |
| 2017 Q3 | 88.03 Million CNY | 41.73% |
| 2017 Q2 | 62.11 Million CNY | -0.0% |
| 2017 FY | 300.31 Million CNY | 44.43% |
| 2017 Q4 | 88.03 Million CNY | 0.0% |
| 2017 Q1 | 62.11 Million CNY | 28.28% |
| 2016 Q2 | 55.53 Million CNY | -0.0% |
| 2016 FY | 207.92 Million CNY | 17.23% |
| 2016 Q3 | 48.42 Million CNY | -12.8% |
| 2016 Q1 | 55.53 Million CNY | 32.28% |
| 2016 Q4 | 48.42 Million CNY | 0.0% |
| 2015 Q4 | 41.98 Million CNY | 0.0% |
| 2015 Q2 | 46.7 Million CNY | -0.0% |
| 2015 Q3 | 41.98 Million CNY | -10.1% |
| 2015 Q1 | 46.7 Million CNY | 10.44% |
| 2015 FY | 177.36 Million CNY | 31.84% |
| 2014 Q4 | 42.28 Million CNY | 0.0% |
| 2014 Q2 | 32.5 Million CNY | 0.0% |
| 2014 Q1 | 32.5 Million CNY | -14.22% |
| 2014 FY | 134.53 Million CNY | 21.7% |
| 2013 Q4 | 37.89 Million CNY | 0.0% |
| 2013 FY | 110.54 Million CNY | 12.69% |
| 2012 FY | 98.09 Million CNY | 0.0% |